2-4 - 2 - 2 - (4 - (chlorophenyl) - 1,3-sulfur-4-il methylsulfur-3,5-dibutyl-6 - (pirrolidin-1-il) pyridine-4-il phenylacetyl-l-methyloxalamine monohydrochloride

摘要

As for the formula compound (I): 2 - {4 - [2 - ([2 - (4-chlorophenyl) - 1,3-thiazol-4-yl) methyl} s-3,5-dioxo-6 - (pirrolidin-1-i L) pyridin-4-il) phenyl -, ethyl-methoxychlor-methoxychlor-monohydrochloride and its crystal form, which is characterized by the largest eel-2-theta peak, 6,7,7. It also mentions a pharmacist who contains the compound, as well as a preparation and pre procedure, which is an effective tool for the treatment of cardiovascular disease or kidney disease.